Business Context and Reporting Period
This Form 8-K filing by The Clorox Company (Delaware) covers the date of October 6, 2004. The report details the entry into a Material Definitive Agreement involving a Share Exchange Agreement with Henkel KGaA and its wholly-owned subsidiary, HC Investments, Inc.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity figures. The document focuses exclusively on the corporate transaction structure.
Material Changes and Transaction Details
- Share Exchange Agreement: On October 6, 2004, The Clorox Company entered into an agreement with Henkel KGaA and HC Investments, Inc.
- Shareholder Structure: HC Investments, Inc. is identified as a wholly-owned subsidiary of Henkel Corporation (itself a subsidiary of Henkel KGaA) and owns 61,386,509 shares of The Clorox Company common stock.
- Board Representation: Henkel KGaA currently has three nominees serving on The Clorox Company board of directors under existing agreements.
- Approval: The Share Exchange Agreement was unanimously approved by the disinterested directors of The Clorox Company.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future performance, or specific risk factors beyond the disclosure of the agreement itself. The document references a press release (Exhibit 99-1) for a brief description of the terms and conditions of the Share Exchange Agreement.
Investor Verification Checklist
- Verify the specific terms and conditions of the Share Exchange Agreement in the attached press release (Exhibit 99-1).
- Confirm the total number of shares held by Henkel KGaA affiliates and the percentage of total outstanding stock represented by the 61,386,509 shares held by HC Investments, Inc.
- Review the "Certain Relationships and Transactions" section of the proxy statement dated September 28, 2004, for details on existing agreements between the companies.
- Assess the implications of the unanimous approval by disinterested directors regarding potential conflicts of interest.